vs
瑞思迈（RMD）与Rollins, Inc.（ROL）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Rollins, Inc.的1.6倍（$1.4B vs $906.4M），瑞思迈净利率更高（27.6% vs 11.9%，领先15.7%），瑞思迈同比增速更快（11.0% vs 10.2%），过去两年瑞思迈的营收复合增速更高（7.9% vs 0.8%）
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
Rollins, Inc.是北美知名虫害防治服务商，面向住宅及商业客户提供专业防控服务。公司依托Orkin、HomeTeam Pest Defense等多家全资子公司布局全球业务，覆盖北美、英国等市场，在民用及商用虫害治理领域具备深厚的行业积累与品牌优势。
RMD vs ROL — 直观对比
营收规模更大
RMD
是对方的1.6倍
$906.4M
营收增速更快
RMD
高出0.8%
10.2%
净利率更高
RMD
高出15.7%
11.9%
两年增速更快
RMD
近两年复合增速
0.8%
损益表 — Q4 FY2026 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $906.4M |
| 净利润 | $392.6M | $107.8M |
| 毛利率 | 61.8% | — |
| 营业利润率 | 34.6% | 16.1% |
| 净利率 | 27.6% | 11.9% |
| 营收同比 | 11.0% | 10.2% |
| 净利润同比 | 13.9% | 2.5% |
| 每股收益（稀释后） | $2.68 | $0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RMDROL
| Q2 26 | $1.4B | — | ||
| Q1 26 | — | $906.4M | ||
| Q4 25 | $1.4B | $912.9M | ||
| Q3 25 | $1.3B | $1.0B | ||
| Q2 25 | $1.3B | $999.5M | ||
| Q1 25 | $1.3B | $822.5M | ||
| Q4 24 | $1.3B | $832.2M | ||
| Q3 24 | $1.2B | $916.3M |
净利润RMDROL
| Q2 26 | $392.6M | — | ||
| Q1 26 | — | $107.8M | ||
| Q4 25 | $392.6M | $116.4M | ||
| Q3 25 | $348.5M | $163.5M | ||
| Q2 25 | $379.7M | $141.5M | ||
| Q1 25 | $365.0M | $105.2M | ||
| Q4 24 | $344.6M | $105.7M | ||
| Q3 24 | $311.4M | $136.9M |
毛利率RMDROL
| Q2 26 | 61.8% | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 61.8% | — | ||
| Q3 25 | 61.5% | — | ||
| Q2 25 | 60.8% | — | ||
| Q1 25 | 59.3% | — | ||
| Q4 24 | 58.6% | — | ||
| Q3 24 | 58.6% | — |
营业利润率RMDROL
| Q2 26 | 34.6% | — | ||
| Q1 26 | — | 16.1% | ||
| Q4 25 | 34.6% | 17.5% | ||
| Q3 25 | 33.4% | 21.9% | ||
| Q2 25 | 33.7% | 19.8% | ||
| Q1 25 | 33.0% | 17.3% | ||
| Q4 24 | 32.5% | 18.1% | ||
| Q3 24 | 31.6% | 20.9% |
净利率RMDROL
| Q2 26 | 27.6% | — | ||
| Q1 26 | — | 11.9% | ||
| Q4 25 | 27.6% | 12.8% | ||
| Q3 25 | 26.1% | 15.9% | ||
| Q2 25 | 28.2% | 14.2% | ||
| Q1 25 | 28.3% | 12.8% | ||
| Q4 24 | 26.9% | 12.7% | ||
| Q3 24 | 25.4% | 14.9% |
每股收益（稀释后）RMDROL
| Q2 26 | $2.68 | — | ||
| Q1 26 | — | $0.22 | ||
| Q4 25 | $2.68 | $0.24 | ||
| Q3 25 | $2.37 | $0.34 | ||
| Q2 25 | $2.58 | $0.29 | ||
| Q1 25 | $2.48 | $0.22 | ||
| Q4 24 | $2.34 | $0.22 | ||
| Q3 24 | $2.11 | $0.28 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.4B | $116.5M |
| 总债务越低越好 | $663.8M | $650.6M |
| 股东权益账面价值 | $6.3B | $1.4B |
| 总资产 | $8.5B | $3.2B |
| 负债/权益比越低杠杆越低 | 0.11× | 0.47× |
8季度趋势，按日历期对齐
现金及短期投资RMDROL
| Q2 26 | $1.4B | — | ||
| Q1 26 | — | $116.5M | ||
| Q4 25 | $1.4B | $100.0M | ||
| Q3 25 | $1.4B | $127.4M | ||
| Q2 25 | $1.2B | $123.0M | ||
| Q1 25 | $932.7M | $201.2M | ||
| Q4 24 | $521.9M | $89.6M | ||
| Q3 24 | $426.4M | $95.3M |
总债务RMDROL
| Q2 26 | $663.8M | — | ||
| Q1 26 | — | $650.6M | ||
| Q4 25 | $403.9M | $486.1M | ||
| Q3 25 | $408.7M | $485.7M | ||
| Q2 25 | $658.4M | $485.3M | ||
| Q1 25 | $663.1M | $485.5M | ||
| Q4 24 | $662.9M | $395.3M | ||
| Q3 24 | $667.6M | — |
股东权益RMDROL
| Q2 26 | $6.3B | — | ||
| Q1 26 | — | $1.4B | ||
| Q4 25 | $6.3B | $1.4B | ||
| Q3 25 | $6.1B | $1.5B | ||
| Q2 25 | $6.0B | $1.4B | ||
| Q1 25 | $5.5B | $1.4B | ||
| Q4 24 | $5.3B | $1.3B | ||
| Q3 24 | $5.2B | $1.3B |
总资产RMDROL
| Q2 26 | $8.5B | — | ||
| Q1 26 | — | $3.2B | ||
| Q4 25 | $8.5B | $3.1B | ||
| Q3 25 | $8.3B | $3.2B | ||
| Q2 25 | $8.2B | $3.2B | ||
| Q1 25 | $7.6B | $2.9B | ||
| Q4 24 | $7.1B | $2.8B | ||
| Q3 24 | $7.2B | $2.8B |
负债/权益比RMDROL
| Q2 26 | 0.11× | — | ||
| Q1 26 | — | 0.47× | ||
| Q4 25 | 0.06× | 0.35× | ||
| Q3 25 | 0.07× | 0.32× | ||
| Q2 25 | 0.11× | 0.34× | ||
| Q1 25 | 0.12× | 0.36× | ||
| Q4 24 | 0.13× | 0.30× | ||
| Q3 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $118.4M |
| 自由现金流经营现金流 - 资本支出 | — | $111.2M |
| 自由现金流率自由现金流/营收 | — | 12.3% |
| 资本支出强度资本支出/营收 | — | 0.8% |
| 现金转化率经营现金流/净利润 | — | 1.10× |
| 过去12个月自由现金流最近4个季度 | — | $621.1M |
8季度趋势，按日历期对齐
经营现金流RMDROL
| Q2 26 | — | — | ||
| Q1 26 | — | $118.4M | ||
| Q4 25 | $339.7M | $164.7M | ||
| Q3 25 | $457.3M | $191.3M | ||
| Q2 25 | $538.8M | $175.1M | ||
| Q1 25 | $578.7M | $146.9M | ||
| Q4 24 | $308.6M | $188.2M | ||
| Q3 24 | $325.5M | $146.9M |
自由现金流RMDROL
| Q2 26 | — | — | ||
| Q1 26 | — | $111.2M | ||
| Q4 25 | $311.2M | $159.0M | ||
| Q3 25 | $414.4M | $182.8M | ||
| Q2 25 | $508.2M | $168.0M | ||
| Q1 25 | $557.9M | $140.1M | ||
| Q4 24 | $288.0M | $184.0M | ||
| Q3 24 | $307.7M | $139.4M |
自由现金流率RMDROL
| Q2 26 | — | — | ||
| Q1 26 | — | 12.3% | ||
| Q4 25 | 21.9% | 17.4% | ||
| Q3 25 | 31.0% | 17.8% | ||
| Q2 25 | 37.7% | 16.8% | ||
| Q1 25 | 43.2% | 17.0% | ||
| Q4 24 | 22.5% | 22.1% | ||
| Q3 24 | 25.1% | 15.2% |
资本支出强度RMDROL
| Q2 26 | — | — | ||
| Q1 26 | — | 0.8% | ||
| Q4 25 | 2.0% | 0.6% | ||
| Q3 25 | 3.2% | 0.8% | ||
| Q2 25 | 2.3% | 0.7% | ||
| Q1 25 | 1.6% | 0.8% | ||
| Q4 24 | 1.6% | 0.5% | ||
| Q3 24 | 1.5% | 0.8% |
现金转化率RMDROL
| Q2 26 | — | — | ||
| Q1 26 | — | 1.10× | ||
| Q4 25 | 0.87× | 1.41× | ||
| Q3 25 | 1.31× | 1.17× | ||
| Q2 25 | 1.42× | 1.24× | ||
| Q1 25 | 1.59× | 1.40× | ||
| Q4 24 | 0.90× | 1.78× | ||
| Q3 24 | 1.05× | 1.07× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
